These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31809736)

  • 21. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
    Han Y; Li QW
    Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Starting the conversation: CRISPR's role in India.
    Udwadia F; Singh S
    Indian J Med Ethics; 2019; 4 (NS)(4):300-303. PubMed ID: 31213419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy.
    Xiao Q; Guo D; Chen S
    Front Cell Infect Microbiol; 2019; 9():69. PubMed ID: 30968001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR therapy towards an HIV cure.
    Herrera-Carrillo E; Gao Z; Berkhout B
    Brief Funct Genomics; 2020 May; 19(3):201-208. PubMed ID: 31711197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.
    Allers K; Schneider T
    Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4
    Liu Z; Chen S; Jin X; Wang Q; Yang K; Li C; Xiao Q; Hou P; Liu S; Wu S; Hou W; Xiong Y; Kong C; Zhao X; Wu L; Li C; Sun G; Guo D
    Cell Biosci; 2017; 7():47. PubMed ID: 28904745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the editing patterns and editing efficiencies of TALEN and CRISPR-Cas9 when targeting the human CCR5 gene.
    Nerys-Junior A; Braga-Dias LP; Pezzuto P; Cotta-de-Almeida V; Tanuri A
    Genet Mol Biol; 2018; 41(1):167-179. PubMed ID: 29583154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of CRISPR/Cas associated technologies for cell transplant applications.
    Cowan PJ
    Curr Opin Organ Transplant; 2016 Oct; 21(5):461-6. PubMed ID: 27517504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects of CRISPR/Cas9 for HIV Elimination.
    Seclen E
    AIDS Rev; 2019; 21(2):109-111. PubMed ID: 31332399
    [No Abstract]   [Full Text] [Related]  

  • 31. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
    Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
    Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR genome editing of murine hematopoietic stem cells to create
    Rajan SS; Li L; Kweh MF; Kunkalla K; Amin AD; Agarwal NK; Vega F; Schatz JH
    Blood Adv; 2019 Jun; 3(12):1788-1794. PubMed ID: 31189527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clustered Regularly Interspaced Short Palindromic Repeats System of Genome Engineering in Embryos to Repair Genes.
    Niazvand F; Fathinezhad Z; Alfuraiji N; Etajuri EA; Amini-Chermahini F; Chehelgerdi M; Ranjbar R
    J Biomed Nanotechnol; 2021 Mar; 17(3):331-356. PubMed ID: 33875070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV.
    Almeida MJ; Matos A
    Curr HIV Res; 2019; 17(5):306-323. PubMed ID: 31652113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.
    Yu KR; Natanson H; Dunbar CE
    Hum Gene Ther; 2016 Oct; 27(10):729-740. PubMed ID: 27483988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E Pluribus Unum ("Out of Many, One"): CRISPR Modeling of Myeloid Expansion.
    Shin J; Corn JE
    Cell Stem Cell; 2017 Oct; 21(4):415-416. PubMed ID: 28985519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers.
    Solloch UV; Lang K; Lange V; Böhme I; Schmidt AH; Sauter J
    Hum Immunol; 2017 Nov; 78(11-12):710-717. PubMed ID: 28987960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Include egg donors in CRISPR gene-editing debate.
    Niemiec E; Howard HC
    Nature; 2019 Nov; 575(7781):51. PubMed ID: 31690864
    [No Abstract]   [Full Text] [Related]  

  • 39.
    Xu H; Luo D; Gao X; Liu X; Wang Q; Sun A; Shen J; He R; Lu G; Li K; Zhang J; Xiao L
    J Biomed Nanotechnol; 2019 Apr; 15(4):662-673. PubMed ID: 30841961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of Gene Expression by Polymer Nanocapsule Delivery of DNA Cassettes Encoding Small RNAs.
    Yan M; Wen J; Liang M; Lu Y; Kamata M; Chen IS
    PLoS One; 2015; 10(6):e0127986. PubMed ID: 26035832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.